- Supported exchanges /
- NSE /
- SUVEN.NSE
Suven Life Sciences Limited (SUVEN NSE) stock market data APIs
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
Suven Life Sciences Limited Financial Data Overview
141.84 | |
141.07 | |
- | |
146.02 | |
140 | |
60.75-169.3 | |
31 843 M | |
218 M | |
89 016 K | |
-1.46 | |
1.639 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Suven Life Sciences Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 89 016 K
- EBITDA -1 308 526 976
- Earnings Per Share -5.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Suven Life Sciences Limited Earnings via APIs
- Latest Release 2022-11-10
- EPS/Forecast 0
Get Suven Life Sciences Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: